Scarica l'app Stockscreener
18.00
4.90%
0.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DNLI Giù?
Forum
Previsione
Precedente Chiudi:
$17.16
Aprire:
$16.93
Volume 24 ore:
1.44M
Relative Volume:
0.78
Capitalizzazione di mercato:
$2.64B
Reddito:
$340.81M
Utile/perdita netta:
$-419.65M
Rapporto P/E:
-6.3158
EPS:
-2.85
Flusso di cassa netto:
$-402.10M
1 W Prestazione:
+3.21%
1M Prestazione:
+6.13%
6M Prestazione:
+31.48%
1 anno Prestazione:
-25.68%
Intervallo 1D:
$16.87
$18.23
Intervallo di 1 settimana:
$16.85
$18.23
Portata 52W:
$10.57
$26.18
Denali Therapeutics Inc Stock (DNLI) Company Profile
Nome
Denali Therapeutics Inc
Settore
Industria
Telefono
(650) 866-8547
Indirizzo
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Confronta DNLI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
18.00 | 2.52B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | Ripresa | Morgan Stanley | Overweight |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2025-01-07 | Iniziato | Robert W. Baird | Outperform |
| 2025-01-03 | Iniziato | William Blair | Outperform |
| 2024-12-16 | Aggiornamento | Stifel | Hold → Buy |
| 2024-10-10 | Ripresa | Raymond James | Mkt Perform |
| 2024-10-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-09-06 | Iniziato | B. Riley Securities | Buy |
| 2023-01-30 | Iniziato | SVB Securities | Outperform |
| 2022-12-05 | Iniziato | Cowen | Outperform |
| 2022-11-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-02 | Iniziato | BofA Securities | Buy |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-12-10 | Ripresa | Raymond James | Mkt Perform |
| 2021-09-21 | Iniziato | Oppenheimer | Outperform |
| 2021-09-01 | Iniziato | SMBC Nikko | Outperform |
| 2021-05-18 | Iniziato | UBS | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-02-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-02-24 | Iniziato | Jefferies | Buy |
| 2020-02-19 | Iniziato | Stifel | Hold |
| 2020-01-27 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-26 | Iniziato | Wedbush | Neutral |
| 2019-09-13 | Iniziato | Nomura | Buy |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Iniziato | Janney | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-01-02 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Iniziato | Goldman | Neutral |
| 2018-01-02 | Iniziato | JP Morgan | Overweight |
| 2018-01-02 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Denali Therapeutics Inc Borsa (DNLI) Ultime notizie
Transcript : Denali Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12 - MarketScreener
How Denali Therapeutics Inc. stock trades during market volatility2025 Volatility Report & Reliable Trade Execution Plans - newser.com
How risky is Denali Therapeutics Inc. (4DN) stock compared to peers - newser.com
Denali Therapeutics announces board and leadership changes By Investing.com - Investing.com Nigeria
How strong dollar benefits Denali Therapeutics Inc. (4DN) stockJuly 2025 Trends & Community Consensus Picks - newser.com
Why Denali Therapeutics Inc. (4DN) stock benefits from AI revolution2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Is Denali Therapeutics Inc. (4DN) stock at risk of policy regulationTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Is Denali Therapeutics Inc. stock a defensive play in 2025Market Risk Summary & Risk Managed Investment Strategies - newser.com
Will Denali Therapeutics Inc. stock gain from lower inflationSwing Trade & High Conviction Investment Ideas - newser.com
Is Denali Therapeutics Inc. stock a contrarian buy2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Is Denali Therapeutics Inc. (4DN) stock positioned for digital growth eraQuarterly Investment Review & Capital Efficient Trade Techniques - newser.com
Published on: 2025-11-19 17:06:18 - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesTrade Exit Summary & Weekly Stock Breakout Alerts - newser.com
Applying sector rotation models to Denali Therapeutics Inc.Quarterly Risk Review & Weekly Return Optimization Alerts - newser.com
How Denali Therapeutics Inc. (4DN) stock performs in easing cyclesJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
Denali Therapeutics Inc. (4DN.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Denali Therapeutics Inc. stock supported by strong cash flowsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Denali Therapeutics Inc. (4DN) stock outperform small cap peers2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Why Denali Therapeutics Inc. stock remains on watchlists2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
Will Denali Therapeutics Inc. (4DN) stock beat international competitionJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Why Denali Therapeutics Inc. stock is favored by pension fundsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Will Denali Therapeutics Inc. stock outperform Nasdaq indexIndex Update & Weekly High Return Stock Forecasts - newser.com
Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):